Global Pharmaceutical companies unite and collaborate on CSR Industry issues to solve growing mis-trust and increase stakeholder confidence

- Leading global pharmaceutical companies will join forces at the Executive Leadership Roundtable in June organised by CSR Data Networks, to discuss current and emerging CSR issues in the wake of a fierce backlash to the industries dilemma in seeking public trust and stakeholder confidence.

The Executive Leadership roundtable is a network of like-minded company leaders who identify, analyse and address current and emerging Industry issues on corporate social responsibility.

Executive leaders from the largest pharmaceutical companies in the world will debate growing industry trends with leaders from a variety of fields associated with the pharmaceutical industry, including international governmental bodies, non-governmental organisations, SRI Analysts, inter-governmental agencies and CSR associated bodies.

The distinctive open dialogue roundtable will debate common challenges and exchange ideas to create added business value to existing CSR programmes and strategies. The open discussion will explore what it takes to turn challenge into opportunity and drive business CSR development and growth in "The New Business Era" whilst providing a provocative inquiry into the impact of key outside organisations on the global pharmaceutical community.

Jupiter Asset Management, ISIS, Morley Fund Management, Henderson Global Investors, The Co-operative Insurance Agency, Hermes Investment Management are a few of the leading financial organisations participating in the roundtable. Their representation makes up billions of dollars in investment where they will debate the challenges they believe are hindering the growth of the pharmaceutical industry.

New socially responsible investment standards demands a fundamental shift in business practices which go beyond mere compliance. The Executive leadership roundtable will address the full spectrum of issues to ensure leaders have the information and tools necessary to promote public trust.

Sally Durcan, Director, CSR Data Networks said, the discussion will be 2 insightful days, focusing 100% on industry challenges to come out at the end with clearly defined goals and identified tools of development which are necessary to increase stakeholder confidence and demonstrate they are taking the appropriate action in dealing with pressing issues at the forefront of industry development".

Companies participating in the CSR Executive Leadership Roundtable will have an active involvement into the discussion topics/questions to ensure all issues are successfully addressed. To find out more information please visit www.csrdatanetworks.com